114 related articles for article (PubMed ID: 35444087)
21. Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).
Khan MS; Omar K; Ahmed K; Gan C; Van Hemelrijck M; Nair R; Thurairaja R; Rimington P; Dasgupta P
Eur Urol; 2020 Jan; 77(1):110-118. PubMed ID: 31740072
[TBL] [Abstract][Full Text] [Related]
22. The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A propensity score matched analysis.
Su X; Wu K; Wang S; Su W; Li C; Li B; Mao X
Cancer Med; 2020 Oct; 9(20):7590-7600. PubMed ID: 32869540
[TBL] [Abstract][Full Text] [Related]
23. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of 30-day early and 90-day late morbidity and mortality of radical cystectomy during a 13-year follow-up: a comparative propensity-score matched analysis of complications between neobladder and ileal conduit.
Kim SH; Yu A; Jung JH; Lee YJ; Lee ES
Jpn J Clin Oncol; 2014 Jul; 44(7):677-85. PubMed ID: 24791782
[TBL] [Abstract][Full Text] [Related]
25. External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center.
Li K; Yang X; Zhuang J; Cai L; Han J; Yu H; Zhou Z; Lv J; Feng D; Yuan B; Wu Q; Li P; Cao Q; Lu Q
BMC Urol; 2022 Mar; 22(1):41. PubMed ID: 35313884
[TBL] [Abstract][Full Text] [Related]
26. Intraoperative hypothermia is a significant prognostic predictor of radical cystectomy especially for stage II muscle-invasive bladder cancer.
Morozumi K; Mitsuzuka K; Takai Y; Katsumata Y; Kuromoto A; Hoshi S; Numahata K; Arai Y
Medicine (Baltimore); 2019 Jan; 98(2):e13962. PubMed ID: 30633177
[TBL] [Abstract][Full Text] [Related]
27. [Clinical experiences of laparoscopic radical cystectomy and urinary diversion in the elderly patients with bladder cancer].
Yang FY; Wang WK; Liu S; Song LM; Xing NZ
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(14):1101-1105. PubMed ID: 30982260
[No Abstract] [Full Text] [Related]
28. Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study.
Brassetti A; Cacciamani G; Anceschi U; Ferriero M; Tuderti G; Miranda G; Mastroianni R; Desai M; Aron M; Gill I; Gallucci M; Simone G
World J Urol; 2020 Apr; 38(4):837-843. PubMed ID: 31190152
[TBL] [Abstract][Full Text] [Related]
29. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
Gschwend JE; Heck MM; Lehmann J; Rübben H; Albers P; Wolff JM; Frohneberg D; de Geeter P; Heidenreich A; Kälble T; Stöckle M; Schnöller T; Stenzl A; Müller M; Truss M; Roth S; Liehr UB; Leißner J; Bregenzer T; Retz M
Eur Urol; 2019 Apr; 75(4):604-611. PubMed ID: 30337060
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
31. [Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer].
Huang HW; Yan B; Shang MX; Liu LB; Hao H; Xi ZJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):698-705. PubMed ID: 31420625
[TBL] [Abstract][Full Text] [Related]
32. Robot Assisted Radical Cystectomy vs Open Radical Cystectomy: Over 10 years of the Mayo Clinic Experience.
Faraj KS; Abdul-Muhsin HM; Rose KM; Navaratnam AK; Patton MW; Eversman S; Singh R; Eversman WG; Cheney SM; Tyson MD; Castle EP
Urol Oncol; 2019 Dec; 37(12):862-869. PubMed ID: 31526651
[TBL] [Abstract][Full Text] [Related]
33. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
[TBL] [Abstract][Full Text] [Related]
34. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
35. Oncological outcome according to attainment of pentafecta after robot-assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database.
Oh JJ; Lee S; Ku JH; Kwon TG; Kim TH; Jeon SH; Lee SH; Nam JK; Kim WS; Jeong BC; Lee JY; Hong SH; Rha KH; Han WK; Ham WS; Lee YG; Lee YS; Park SY; Yoon YE; Kang SG; Kang SH;
BJU Int; 2021 Feb; 127(2):182-189. PubMed ID: 32682331
[TBL] [Abstract][Full Text] [Related]
36. [Clinical outcomes for young patients with muscular invasive bladder cancer who received robot-assisted radical cystectomy].
Wang JG; Zhu ZW; Fan YF; Zhang XP
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(12):861-865. PubMed ID: 33789368
[No Abstract] [Full Text] [Related]
37. Comparison of 2-Year Oncological Outcome and Early Recurrence Patterns in Patients with Urothelial Bladder Carcinoma Treated with Open or Robot-Assisted Radical Cystectomy with an Extracorporeal Urinary Diversion.
Niegisch G; Nini A; Michalski R; Henn A; Mally D; Albers P; Rabenalt R
Urol Int; 2018; 101(2):224-231. PubMed ID: 30045033
[TBL] [Abstract][Full Text] [Related]
38. Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.
Hinsenveld FJ; Boormans JL; van der Poel HG; van der Schoot DKE; Vis AN; Aben KKH; Arends TJ; Ausems PJ; Baselmans D; Berger C; Berrens A; Bickerstaffe H; Bos SD; Braam M; Buddingh KT; Claus S; Dekker K; van Doeveren T; Einerhand S; Fossion L; van Gennep EJ; van Ginkel N; Palacios G; Hermans T; Hobijn MM; van Huystee SH; Jaspers-Valentijn M; Klaver OS; Koldewijn EL; Korsten L; Lenting A; Lentjes KJ; Luiting HB; van der Meer S; Nieuwenhuijzen JA; Noordzij MA; Nooter RI; Notenboom C; Oomen R; van Roermund J; de Rooij J; Roshani H; Schrier BP; van der Slot MA; Somford DM; Stelwagen PJ; Stroux A; van der West A; Wijsman BP; Windt W; van Zanten P; van Beek SC;
Urol Oncol; 2022 Feb; 40(2):60.e1-60.e9. PubMed ID: 34303597
[TBL] [Abstract][Full Text] [Related]
39. Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study.
Lenfant L; Verhoest G; Campi R; Parra J; Graffeille V; Masson-Lecomte A; Vordos D; de La Taille A; Roumiguie M; Lesourd M; Taksin L; Misraï V; Grande P; Vaessen C; Ploussard G; Granger B; Rouprêt M
World J Urol; 2018 Nov; 36(11):1711-1718. PubMed ID: 29744571
[TBL] [Abstract][Full Text] [Related]
40. Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes.
Tan WS; Sridhar A; Ellis G; Lamb B; Goldstraw M; Nathan S; Hines J; Cathcart P; Briggs T; Kelly J
Urol Oncol; 2016 Jun; 34(6):257.e1-9. PubMed ID: 26968561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
